Cover Image
市場調查報告書

癌症性疼痛:全球臨床實驗趨勢

Cancer Pain Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 237452
出版日期 內容資訊 英文 272 Pages
訂單完成後即時交付
價格
Back to Top
癌症性疼痛:全球臨床實驗趨勢 Cancer Pain Global Clinical Trials Review, H2, 2016
出版日期: 2016年11月30日 內容資訊: 英文 272 Pages
簡介

本報告提供癌症性疼痛臨床實驗相關之最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,實驗對像採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 癌症性疼痛
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:中樞神經系統疾病治療藥臨床實驗上癌症性疼痛的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:中樞神經系統疾病治療藥臨床實驗上癌症性疼痛的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

癌症性疼痛治療藥臨床實驗主要的參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Johnson & Johnson
    • Janssen Global Services, LLC
    • Mundipharma International Ltd
    • 麒麟集團
    • GW Pharmaceuticals Plc
    • Grunenthal GmbH
    • 武田藥品工業
    • Pfizer Inc.
    • 大塚集團
    • Kyowa Hakko Kirin
  • 有代表性的研究機關·醫院臨床實驗概要
    • Alberta Health Services
    • Erasmus MC
    • Mario Negri Institute for Pharmacological Research
    • Mayo Clinic
    • Norwegian University of Science and Technology
    • Assistance Publique - Hopitaux de Paris
    • Chinese University of Hong Kong
    • Chonbuk National University Hospital
    • Gloucestershire Hospitals NHS Trust
    • Indiana University

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3961CTIDB

GlobalData's clinical trial report, "Cancer Pain Global Clinical Trials Review, H2, 2016" provides an overview of Cancer Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Five Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Cancer Pain to Central Nervous System Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Cancer Pain to Central Nervous System Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Cancer Pain Therapeutics Clinical Trials 27
  • Prominent Drugs 29
  • Latest Clinical Trials News on Cancer Pain 30
  • Sep 30, 2016: Grunenthal's cebranopadol, a novel strong analgesic, meets primary efficacy endpoint in Phase 3 trial in cancer pain 30
  • Clinical Trial Profile Snapshots 31

Appendix 269

  • Abbreviations 269
  • Definitions 269
  • Research Methodology 270
  • Secondary Research 270
  • About GlobalData 271
  • Contact Us 271
  • Disclaimer 271
  • Source 272

List of Tables

List of Tables

  • Cancer Pain Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Cancer Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Cancer Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Cancer Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
  • Cancer Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
  • Cancer Pain Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
  • Cancer Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
  • Cancer Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
  • Proportion of Cancer Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 14
  • Cancer Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Cancer Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Cancer Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 17
  • Cancer Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Cancer Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Cancer Pain Therapeutics, Global, Clinical Trials by Phase, 2016* 20
  • Cancer Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
  • Cancer Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Cancer Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Cancer Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Cancer Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
  • Cancer Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Cancer Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
  • Cancer Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List of Figures

List of Figures

  • Cancer Pain Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Cancer Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Cancer Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Cancer Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
  • Cancer Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
  • Cancer Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
  • Cancer Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
  • Cancer Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
  • Proportion of Cancer Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 14
  • Cancer Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Cancer Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Cancer Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 17
  • Cancer Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Cancer Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Cancer Pain Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
  • Cancer Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
  • Cancer Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Cancer Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Cancer Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Cancer Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
  • Cancer Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Cancer Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
  • Cancer Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
  • GlobalData Methodology 270
Back to Top